Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

We performed a meta-analysis of 3 genome-wide association studies to identify additional common variants influencing chronic lymphocytic leukemia (CLL) risk. The discovery phase was composed of genome-wide association study data from 1121 cases and 3745 controls. Replication analysis was performed in 861 cases and 2033 controls. We identified a novel CLL risk locus at 6p21.33 (rs210142; intronic to the BAK1 gene, BCL2 antagonist killer 1; P = 9.47 × 10(-16)). A strong relationship between risk genotype and reduced BAK1 expression was shown in lymphoblastoid cell lines. This finding provides additional support for polygenic inheritance to CLL and provides further insight into the biologic basis of disease development.

[1]  E. Halperin,et al.  lymphocytic leukemia ) influences the risk of chronic BAK1 , 2012 .

[2]  P. Broderick,et al.  Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk , 2011, British journal of haematology.

[3]  Celine M Vachon,et al.  Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. , 2011, Blood.

[4]  Simon C. Potter,et al.  The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study , 2011, PLoS genetics.

[5]  Kevin M. Brown,et al.  Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 , 2010, Nature Genetics.

[6]  E. Campo,et al.  Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.

[7]  S. Kaufmann,et al.  Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis* , 2009, The Journal of Biological Chemistry.

[8]  Guy Pratt,et al.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.

[9]  R. Wilkins.  Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.

[10]  T. Eisen,et al.  Bmc Cancer Identification of Low Penetrance Alleles for Lung Cancer: the Genetic Lung Cancer Predisposition Study (gelcaps) , 2008 .

[11]  D. George,et al.  Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. , 2007, Genes & development.

[12]  E. Papaemmanuil,et al.  National study of colorectal cancer genetics , 2007, British Journal of Cancer.

[13]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[14]  S. Korsmeyer,et al.  Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Hemminki,et al.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. , 2004, Blood.

[16]  G. Packham,et al.  Chronic lymphocytic leukemia : revelations from the B-cell receptor , 2004 .

[17]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[18]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[19]  G. Evan,et al.  Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.

[20]  Weiss Ns.  Geographical variation in the incidence of the leukemias and lymphomas. , 1979 .

[21]  N. Weiss.  Geographical variation in the incidence of the leukemias and lymphomas. , 1979, National Cancer Institute monograph.